FDA is proposing a study which I call ?less is more.? The study is long overdue. They are concerned that too many risks are being presented in television ads and perhaps this confuses consumers. The basic lesson of advertising is to focus on the main point or compelling benefit if you want people to remember […]
Tag Archives | prescription drug pricing
By Bob Ehrlich
August 18, 2014
DTC in Perspective: Drug Pricing Criticism
The Senate is after drug maker Gilead to explain its high price for hepatitis drug Solvadi. The request came from Ron Wyden and Chuck Grassley and asked about differences in U.S. and foreign pricing. Solvadi is expensive at about $80,000 for a course of treatment. I think these senators are asking what they already know. […]
